Sotos syndrome …

Developmental Malformations

Updated 11.29.2023
Released 09.29.2006
Expires For CME 11.29.2026

Sotos syndrome

Authors: Christina Grant MD PhD, Andrea Cohen MD

See Contributor Disclosures

Editor: Ganeshwaran H Mochida MD

Sotos syndrome

In This Article

Quick Link

Introduction

Overview

Sotos syndrome is a Mendelian disorder of the epigenetic machinery that is classically characterized by the triad of distinctive craniofacial features, overgrowth, and intellectual disability. NSD1 haploinsufficiency was determined to be the major cause of typical Sotos syndrome. Microdeletions of NSD1 were identified in Japanese Sotos patients whereas intragenic mutations were found in most non-Japanese patients. A Sotos-like presentation can also be associated with a number of other genes, most commonly variants of NFIX (Malan syndrome). The majority of Sotos syndrome cases are sporadic, but a few families with an autosomal dominant transmission have been reported. The clinical phenotypes of Sotos syndrome, Malan syndrome, and Sotos-like syndromes are discussed. In addition, the diagnostic and management guidelines are reviewed.

Key points

	• Overgrowth, characteristic facial gestalt, and learning disability or behavioral abnormalities are considered the cardinal clinical criteria of Sotos syndrome.
	• Cardiac anomalies, renal anomalies, hypodontia, seizures, or scoliosis are considered as major features.
	• Genetic testing to confirm the diagnosis is highly recommended because of the remarkable clinical overlap with other overgrowth syndromes.
	• NSD1 is the most commonly implicated gene in patients with Sotos-like presentation and should be included in the first step when testing any patient with Sotos syndrome.

Historical note and terminology

Sotos syndrome, historically referred to as cerebral gigantism, has been recognized for over 50 years, since the description of five children with macrocephaly, somatic overgrowth, characteristic facial appearance, and intellectual disability by Juan Sotos and his colleagues (49). Thirty years later, the major diagnostic criteria of this syndrome were established (10). In 2002, the genetic etiology of Sotos syndrome was unraveled in a patient carrying an apparently balanced de novo reciprocal translocation t(5; 8)(q35; q24). Since then, heterozygous inactivating variants of the gene NSD1 (nuclear receptor binding SET domain protein 1) have been identified as a major cause and are identified in about 90% of patients with Sotos-like presentation (22; 26). In 2010, pathogenic variants in NFIX were identified in patients with Sotos-like features and initially referred to as Sotos syndrome 2 (31; 42; 60). Subsequently, homozygous variants in the APC2 gene were detected in two siblings with Sotos-like features (03). This autosomal recessive type was originally known as Sotos 3. Further, DNMT3A, SETD2, and GPC3 gene variants or hypomethylation of KCNQ1OT1 may be responsible for clinical features in a few patients with Sotos-like presentation (05; 34).

Terminology. The Sotos syndrome 1/2/3 nomenclature is now nonpreferred. Instead, Sotos syndrome generally refers to affected individuals with NSD1 pathogenic variants, though this term is also used to describe individuals with a clinical diagnosis in the absence of confirmatory genetic testing. Malan syndrome is the current preferred nomenclature for individuals with Sotos-like phenotype and NFIX pathogenic variants. For optimal clarity, it is appropriate to use nomenclature that includes both the genetic etiology and the clinical phenotype in cases in which both are known, eg, NSD1-associated Sotos syndrome or APC2-associated Sotos-like syndrome.

Clinical manifestations

Presentation and course

Sotos syndrome is characterized by the following:

Craniofacial features. Characteristic facial features are present in essentially all Sotos patients with NSD1 variants. This most typically includes a high, prominent forehead and a small, pointed chin, giving the appearance of an inverted pear. Further, individuals frequently have macrodolichocephaly, a receding anterior hairline, hypertelorism, malar flushing, downslanting palpebral fissures, anteverted nostrils, relatively large ears, and highly arched palate (Allanson and Cole 1996; 53; 54). These characteristic facial features change with time; in youth, the face is round with disproportionate prominence of the forehead, whereas in adolescence the face lengthens, with less prominence of the square or pointed chin, and macrocephaly is no longer pronounced but the downslanting palpebral fissures and the high hairline remain distinctive (10; 41; 17). In comparison, patients with Malan syndrome have a long or triangular face, prominent forehead, depressed nasal bridge, deeply set eyes, downslanting palpebral fissures, short nose with anteverted nares and upturned tip, long philtrum, small mouth that is often held open with a thin upper vermillion in a cupid bow shape, an everted lower lip, and a prominent chin. These facial features became more prominent among adults with Malan syndrome, showing more elongated face, prominent chin, deeper skin folds, and more open mouth (43). Mild dysmorphic facial features with normal head circumference were reported in Sotos-like patients (07).

Overgrowth. Height or head circumference more than two standard deviations above the mean have been reported in 90% of children with Sotos syndrome (51). Overgrowth usually starts prenatally and increases rapidly in early childhood before stabilizing above the 97th percentile. However, adult height often ends up in a high-normal range, especially in females (54). This is likely explained by the presence of advanced bone age, which results in earlier closure of epiphyses. However, 20% of patients were described to have normal growth and bone age (29; 07).

Developmental delay and learning disability. Sotos patients typically present with neonatal hypotonia that improves with age. Therefore, walking is usually delayed.

In general, the majority of patients with Sotos syndrome have some degree of learning disability, which may vary from mild to profound learning difficulties requiring lifelong care (18). Although approximately 20% of patients harboring NSD1 variants are reported to have normal learning, patients harboring NFIX variants usually display severe to profound disability (43; 30). Males with Sotos syndrome may be more likely to have a greater degree of intellectual disability than females.

Patients with missense mutations had milder phenotype than those with truncating mutations (45). Severe cognitive impairment was observed in patients harboring large NSD1 deletions (58; 51; 39).

The Sotos syndrome cognitive profile is characterized by relative strength in verbal ability and visuospatial memory but relative weakness in nonverbal reasoning ability and quantitative reasoning. Patients with Sotos syndrome may display greater disability in expressive language when compared to receptive language (28). Furthermore, speech articulation difficulties, including delayed or no speech development, were observed.

Behavioral disturbances with aggressiveness. Although no characteristic behavioral profile has been specified among patients with Sotos and Malan syndrome, neurobehavioral disorders, such as autism-like features, ADHD, and anxious behavior, are common. However, it is not clear that these are more common in individuals with Sotos and Sotos-like syndromes than in other individuals with similar levels of intellectual disability (28). Aggression and self-injurious behavior were also noted. One study suggested that individuals with inactivating variants of NSD1 show fewer behavioral problems, an easier temperament, and fewer internalizing behaviors than those with a clinical diagnosis of Sotos syndrome without identified variants of NSD1, but the study was limited to molecular analysis for large deletions of NSD1 or small variants in a single NSD1 domain (12).

Neuroradiologic anomalies. In general, disturbed development of the midline structures of the brain, such as ventricular dilatation, hypoplastic corpus callosum, heterotopias, periventricular leukomalacia, macrocerebellum, open operculum, and cavum septum pellucidum, are the main neuroradiologic anomalies described in Sotos and Malan syndromes (46). Mild ventriculomegaly may be a relatively common prenatal finding; it was noted in three of eight fetuses with Sotos syndrome in a small retrospective cohort (61). In comparison, Chiari malformation type I, nodular heterotopias, and cortical dysplasia were reported in few patients with Malan syndrome (48; 43). In one study, hypoperfusion of the frontal lobe was noticed in two of the three patients with Sotos syndrome, suggesting some associations with the abnormal behavior noticed in Sotos syndrome (21).

Seizures. Seizures have been described in 50% of patients with Sotos syndrome and 18% of patients with Malan syndrome (43). Of individuals with Sotos syndrome and seizures, 10% to 50% had febrile seizures only (51; 37; 16). In a cohort of individuals with a clinical diagnosis of Sotos syndrome and seizures, two thirds had multiple seizure types, with staring spells, tonic-clonic seizures, and febrile seizures being the most common (16). Temporal lobe epilepsy may include olfactory, gustatory, or auditory hallucinations, automatisms, fear, auras (eg, abdominal aura) with or without behavioral arrest that could be confused with behavioral disorders. Infantile spasms, absence, and myoclonic seizures were also reported. In the majority of cases, seizures were easy to control with common antiepileptic drugs (37; 16).

Dental and oral findings. These include premature or ectopic tooth eruption, hypodontia, enamel hypoplasia, excessive tooth wear, maxillary and mandibular recession, talon cusps, fused teeth, expanded pulp cavity of deciduous teeth, and tooth agenesis (found in 69%) involving the premolars (especially the second) are noted (25). High arched palate and dental crowding were reported in few patients with Malan syndrome (43).

Cardiac findings. Congenital heart defects reported in Sotos syndrome range from single, self-limiting anomalies to complex anomalies requiring interventional surgery. Patent ductus arteriosus and atrial septal defect are among the most frequent congenital heart defects reported (35; 29). In one cohort of patients with Sotos and Malan syndrome, there was a significant association between the presence of neonatal hypotonia and congenital heart defects (30). Noncongenital heart disease, including aortic enlargement and recurrent pericarditis requiring chronic immunosuppressive therapy, have also been reported in rare individuals (20; 30).

Urogenital abnormalities. The most common renal abnormalities are vesicoureteric reflux, hydronephrosis, and hydroureter, but anatomical abnormalities such as duplex kidney, urethral stenosis, pelviureteric junction obstruction, and absent kidney are also recognized (50). They are commonly associated with NSD1 gene microdeletions (35).

Ocular features. Cataracts, megalophthalmos, exotropia, megalocornea, hyperopia, nystagmus, esotropia, optic disk pallor, and retinal dystrophy were reported in Sotos syndrome (23), whereas strabismus, optic nerve atrophy, or hypoplasia were described in 30% of Malan patients (13; 43).

Skeletal anomalies. Scoliosis has been reported in about up to 52% of individuals with NSD1 variants (15; 17). It develops at an early age and can range from a mild to severe with rapidly progressive curving. In comparison, individuals with Malan syndrome often have a marfanoid body habitus, with tall and slender build, long narrow face, and long slender fingers, though these features may only become apparent with age (32; 43).

Tumor risk. The risk of tumors was estimated to be about 2% to 3% (15; 17). Most tumors (45%) developed after the age of five years and were of hematopoietic and neuroectodermal origin (29).

Other features. These include neonatal jaundice, neonatal cutis laxa, feeding problems, hypothyroidism, laryngomalacia, inguinal hernia, craniosynostosis, conductive or sensorineural hearing loss, pneumothorax associated with multiple subpleural blebs, arthrogryposis, hyperpigmentation, hypopigmentation, hypoplastic nails, and recurrent onychocryptosis requiring surgical correction (10; Allanson and Cole 1996; 54; 04; 36; 30).

Prognosis and complications

Sotos syndrome is not a progressive disorder. Thus, long-term survival is typical. Adults with Sotos syndrome who have mild to moderate intellectual disability usually display social isolation, depression, and anxiety. The most common medical problems are scoliosis or contractures, visual difficulties (as a result of strabismus, myopia, glaucoma, nuclear cataract, and retinal atrophy), and increased risk of tumorigenesis (15). Less common medical problems are lymphedema, contracture deformities, dilatation of the aortic arch, and tremors (17). The severity of these medical problems could affect life expectancy (54; 29).

Clinical vignette

Patient 1. A three-year-old boy presented with macrodolichocephaly and developmental delay. He was the fourth child of a healthy nonconsanguineous 39-year-old mother and 45-year-old father. The pregnancy was unremarkable. There was no history of toxemia, preeclampsia, or exposure to any teratogenic agent during the pregnancy. The boy was delivered via normal spontaneous vaginal birth at 38 weeks of gestation. Birth weight, length, and occipitofrontal head circumference measurements were unknown. He had neonatal jaundice, hypotonia, and feeding difficulties, for which he was kept in an incubator for two weeks. Examination showed weight, height, and head circumference of 18.5 kg (+2.5 SD), 101.2 cm (+1.8 SD), and 54 cm (+2.2 SD), respectively. A triangular face, dolichocephaly, hypertelorism with downslanting palpebral fissures, anteverted nostrils, and a pointed chin were noticed.

Sotos syndrome facial features

Patient with Sotos syndrome at the age of (A) 3 years old, (B) 7 years old, and (C) 11 years old. Note the distinctive facial features, including macrocephaly, dolichocephaly, hypertelorism with downslanting palpebral fissures,...

He had hypotonia, but the deep tendon reflexes were slightly brisk. His psychomotor development showed mild delay in terms of head control at the age of seven months, sitting at the age of nine months, and walking alone at 21 months.

The patient’s Portage development test results were abnormal. His most notable deviations were in language and cognitive behavior. His self-help and gross motor skills were mildly delayed at a 3-year level. His EEG showed nonspecific abnormalities. Electromyography and nerve conduction showed axonal neuropathy. An MRI of the brain showed dysplastic corpus callosum, especially in the posterior part, and mild enlargement of the lateral ventricles.

Sotos syndrome (MRIs)

(A) Axial MRI of a patient with Sotos syndrome shows a prominent trigone region of the lateral ventricles and mild dilatation of lateral ventricles. (B) Midsagittal MRI of the same patient showing dysplastic corpus callosum with t...

Bone age at chronological age six years was six years. Examination at the age of seven years showed weight, height, and head circumference of 29.5 kg (+2 SD), 125 cm (+1 SD), and 56.3 cm (+3 SD), respectively. Craniotomy was performed at the age of nine years for cosmetic purpose to improve the shape of the skull. Follow up cranial MRI did not reveal further changes. Ophthalmologic examination, echocardiogram, abdominal ultrasound, and karyotype of cultured peripheral blood lymphocytes were normal. His mother reported that he was inattentive, hyperactive, and aggressive toward the other children. At the age of 11 years, weight, height, and head circumference were 56 kg (+3.2 SD), 147.3 cm (+1 SD), and 58.4 cm (+3.2 SD), respectively. Dental examination at this age showed high-arched palate and malposed teeth with missing left upper second premolar. Molecular genetic analysis of NSD1 was not done.

Patient 2. This 15-month-old male was the third child born to nonconsanguineous healthy parents. His mother’s age at the time of conception was 34 years, and his father’s age was 45 years. The patient had an older brother with epilepsy and a sister with hydroureter and learning disability. Further, the familial history showed maternal and paternal cousins with learning disability. The patient was born at term by normal vaginal delivery, and the pregnancy had been uneventful. His birth weight was 4.5 kg. His birth length and his head circumference were not recorded. From the 3rd day after birth, he developed physiological jaundice that lasted for 15 days. He raised his head at five months, sat alone at eight months, stood with support at nine months, and walked at 13 months. He presented to us at 15 months of age. Weight, length, and head circumference were 16.5 kg (+4.2 SD), 85.5 cm (+2.5 SD), and 50 cm (+2.2 SD), respectively. His face was long with prominent forehead, antimongoloid slanting, large ears, long philtrum, high-arched palate, and pointed chin. The patient demonstrated slight generalized hypotonia and umbilical hernia.

Electromyography and nerve conduction showed axonal neuropathy. Abdominal ultrasonography revealed dilatation of left renal pelvis at the pelviureteric junction. His EEG showed bilateral focal epileptogenic dysfunction. Routine blood examination, thyroid hormone levels, electrocardiogram, and ophthalmologic examination were within normal ranges. His bone age at chronological age 15 months was 32 months. His developmental quotient test was 73. Brian CT revealed brain atrophy. Unfortunately, molecular genetic analysis of NSD1 for the family was not performed.

Biological basis

Etiology and pathogenesis

Truncating mutations, missense mutations in functional domains, partial gene deletions, or 5q35 microdeletions encompassing the entire NSD1 gene are identifiable in the majority (≥ 90%) of individuals with a classic Sotos phenotype. Protein truncation mutations are found throughout the NSD1 gene, whereas missense mutations cluster in the latter half of the gene where functional domains are located (51). The mechanism of generation and size of 5q35 microdeletions differ depending on the ethnic origin of the affected individual. Outside Japan, 5q35 microdeletions are variable in size and predominantly arise through interchromosomal rearrangements (51). In contrast, a uniform 1.9Mb microdeletion, arising through intrachromosomal rearrangements, has been identified in the majority of individuals of Japanese descent with Sotos syndrome (51; 59; 39). Low-copy repeats flanking the Sotos common deletion showed that the deletion arises through nonhomologous recombination utilizing the low-copy repeats (59). An inversion polymorphism that predisposes to the microdeletion is common in Japan and may explain the high recurrence of the 1.9Mb 5q35 microdeletion in the Japanese population, although the frequency of this inversion polymorphism outside Japan is currently not known (59). Generally, the paternal allele is preferentially deleted in the majority of cases with NSD1 microdeletions. This could be partly attributed to the greatly increased recombination rate in men compared with women at the 5q telomere. Mutational hotspots do not exist (51).

NSD1 encodes the protein nuclear receptor-binding SET domain-containing protein 1 (NSD1), also known as histone-lysine N-methyltransferase, H3 lysine-36 specific. NSD1 falls in the class of epigenetic writers, catalyzing the transfer of methyl groups to lysine residues of histone tails. More specifically, it mediates mono- and dimethylation of lysine residue 36 of histone H3 (H3K36) and, at least in vivo, of lysine residue 20 of histone H4 (H4K20) (44). NSD1 regulates transcription via interactions with H3K36 methylation and RNA polymerase II (09).

As a global epigenetic regulator, NSD1 impacts expression of a large number of genes in a manner that is likely both cell type–specific and developmental stage–specific. The precise genetic pathways by which NSD1 haploinsufficiency results in the features of Sotos syndrome are still under investigation. Several possible mechanisms have been proposed and supported by initial studies. The role of NSD1 in the pathogenesis of Sotos syndrome could be mediated through its action as a corepressor of genes that promote growth (26). It is expressed in several tissues including fetal/adult brain, kidney, skeletal muscle, spleen, and thymus, and the NSD1 protein is probably involved in the transcriptional silencing of developmentally regulated genes during embryogenesis. NSD1-mediated H3K36 methylation may also protect a subset of genes from the repressive activity of polycomb repressive complex 2 (PRC2). In Sotos syndrome, reduced NSD1 levels may, therefore, result in excessive PRC2 activity and, thus, to decreased expression of PRC2-regulated genes, a pattern that has been seen in samples from patients with Sotos syndrome (06). It has also been proposed that deregulation of the MAPK/ERK pathway in Sotos syndrome results in altered hypertrophic differentiation of NSD1-expressing chondrocytes and may be a determining factor in statural overgrowth and accelerated skeletal maturation in Sotos syndrome (57). Further, haploinsufficiency of NSD1 results in dysregulated insulin expression (19).

Malan syndrome is caused by heterozygous variants of NFIX clustered mostly in exon 2. NFIX encodes the protein nuclear factor 1 X-type (NFIX). NFIX variants associated with Malan syndrome are thought to cause haploinsufficiency, either by nonsense variants predicted to result in nonsense-mediated decay and, thus, reduced protein translation, or by missense and in-frame deletions predicted to reduce function of the DNA-binding/dimerization domain (32). Functional studies showed the role of NFIX in chondrocyte differentiation and bone formation and its specific involvement in the endochondral ossification process. The overgrowth in patients with dominant NFIX mutations supports a dysregulation of the switch between proliferation and differentiation stages and also suggests that NFIX could act as a negative regulator of the endochondral ossification process (31; 34; 42; 60). There is no genotype-phenotype correlation in Malan syndrome except for an increased risk for epilepsy with 19p13.2 microdeletions (43).

In two Egyptian siblings with Sotos-like features, homozygous mutation of the APC2 gene was identified. Expression of APC2 was revealed to be under the control of NSD1. The knockdown of NSD1 in neuronal cells suppressed the expression of the APC2 gene, which led to developmental defects in the brain. These results strongly indicated that APC2 is a crucial target of NSD1 (03). DNMT3A, SETD2, and GPC3 gene variants or hypomethylation of KCNQ1OT1 may be responsible for clinical features in a few patients with Sotos-like presentation (05; 34).

Differential diagnosis

Confusing conditions

Phenotypic overlap with other overgrowth syndromes exists, in particular with the following:

Weaver syndrome. The facial features of Sotos syndrome and Weaver syndrome are similar, particularly in infancy. However, as children get older, patients with Sotos usually have the characteristic prominent chin. Further, advanced dental maturation is remarkably observed in Sotos syndrome but rarely commented on in Weaver syndrome. Moreover, Sotos syndrome may carry an increased risk for cancers, whereas Weaver syndrome does not. Mutations in the histone methyltransferase EZH2 were shown to cause Weaver syndrome (52).

Marshall-Smith syndrome. Like Malan syndrome, Marshall-Smith syndrome is associated with genetic variants in NFIX but presents with a distinct phenotype. It is characterized by increased birth length with subsequent failure to thrive, prominent forehead, prominent eyes, underdeveloped midface and prominent premaxilla micrognathia, anteverted nares, broad proximal and middle phalanges, disharmonic bone maturation, and respiratory compromise secondary to upper airway obstruction, (31; 42; 60).

Variants associated with Marshall-Smith syndrome have exclusively been found in regions outside of those coding for the DNA binding and dimerization domain, especially in exons 6-8 and sometimes in exons 9 and 10. For several Marshall-Smith-associated variants it has been demonstrated that mutant mRNA does not undergo nonsense mediated decay (31; 47), whereas variants associated with Malan syndrome are instead restricted to the 5’ part of the gene encoding for the DNA binding and dimerization domain (43).

Tatton-Brown-Rahman syndrome. Tatton-Brown-Rahman syndrome is a newer overgrowth syndrome characterized by a tall stature, large head circumference, intellectual disability, and a facial gestalt that is characterized by a round face, heavy, horizontal eyebrows, and narrow palpebral fissures. It is caused by DNMT3A (DNA cytosine 5 methyltransferase 3A) mutations or 2p23 microdeletion (55; 40).

Bannayan-Riley-Ruvalcaba syndrome. Bannayan-Riley-Ruvalcaba syndrome is differentiated by the characteristic lipomatosis and hemangiomatosis and penile freckling in boys, which has not been reported in Sotos syndrome. It is due to PTEN mutations in about 60% of cases.

Beckwith-Wiedemann syndrome. Macroglossia is the hallmark in Beckwith-Wiedemann syndrome but has never been reported in Sotos syndrome. Further, visceromegaly, hemihypertrophy, and embryonal tumors are usually associated with Beckwith-Wiedemann syndrome (05). Hypomethylation of KCNQ1OT1 is the most common cause of Beckwith-Wiedemann syndrome, although it was reported in three patients with Sotos-like features (34).

Benign familial macrocephaly. Benign familial macrocephaly lacks the distinctive facial features of Sotos syndrome.

Simpson-Golabi-Behmel syndrome. Coarse facies, vertebral segmentation defects, supernumerary nipples, dental malocclusion, organomegaly, and diaphragmatic hernia make Simpson-Golabi-Behmel syndrome quite distinct from Sotos syndrome. Besides, it has an X-linked mode of inheritance. It is caused by mutations and deletions in GPC3 (05).

Diagnostic workup

In the majority of individuals with Sotos-like presentation, molecular genetic testing is able to confirm a diagnosis of Sotos syndrome, Malan syndrome, or another overgrowth syndrome. Molecular testing is frequently performed using a multigene panel for overgrowth syndromes that includes NSD1 and NFIX as well as genes for other potentially overlapping syndromes. However, narrower testing, ie, single-gene sequencing of NSD1 or NFIX, and broader testing, eg, exome sequencing, may also be used. Given the relatively high prevalence of 5q35 microdeletions in Sotos syndrome, it is important to select a test that includes deletion/duplication analysis.

In cases in which genetic testing results in a variant of uncertain significance (VUS), genome-wide DNA methylation (DNAme) profiling can be used for variant disambiguation. Disorder-specific DNAme signatures have been defined for a number of genetic conditions caused by disruption of epigenetic regulators, and Sotos syndrome was among the first. For individuals in whom genetic testing was not definitive but did reveal an NSD1 VUS, presence of a characteristic DNAme signature can confirm the diagnosis of Sotos syndrome (14). In the United States, clinical DNAme profiling, including for NSD1-associated Sotos syndrome, is available.

After diagnosis of Sotos syndrome, or if clinical concern is high, thorough evaluation for known features should be performed, if not already done. This may include the following:

	• In the neonatal period, glucose and insulin levels in blood should be evaluated, especially for those displaying irritability and poor feeding (33).
	• Echocardiography to detect cardiac anomalies.
	• X-rays of hands and spine for bone age and scoliosis assessment, respectively.
	• Dental examination must be checked to detect premature eruption or ectopic tooth.
	• Audiometric assessment.
	• Ophthalmologic evaluation.
	• Neuropsychological evaluation, including IQ testing.
	• Echocardiography to detect cardiac anomalies.
	• Abdominal ultrasound is to identify renal anomalies such as vesicoureteric reflux, hydronephrosis, and hydroureter and solid tumors.
	• Brain MRI should be considered, although anomalies of the midline structures are common, but nonspecific. However, the presence of Chiari malformation type 1 is commonly associated with Malan syndrome.
	• EEG should be performed, especially in case of seizures or behavioral disorders.
	• Finally, genetic testing for NSD1, NFIX, or both genes should be performed to confirm the clinical diagnosis (42; 60).

Management

Rehabilitation. No specific treatment is available, but symptomatic treatment for the associated complications depends on age and severity.

	• Treat hypoglycemia with glucose infusion; in persistent hypoglycemia treatment with diazoxide (6 mg/kg/day) should be added (33).
	• Nasal tube feeding should be used in case of poor feeding.
	• For severe congenital abnormalities, cardiac surgery may be recommended.
	• In patients with scoliosis, brace wearing can provide control of the curve progression and delay surgical intervention (11).
	• In patients with tremors propranolol and clonidine may be recommended.
	• Monotherapy with valproic acid is the most frequently used in epilepsy. Less frequently, polytherapy with antiepileptic drugs is used.
	• Methylphenidate (successively up to 30 mg/day) was described to significantly reduce aggression and impulsivity (38).
	• It is noteworthy to mention that management guidelines do not include tumor screening, as the types of tumors detected in Sotos syndrome are diverse and do not have well-defined screening protocols (54).
	• Compression stockings and a lymphedema pump three hours per day should be practiced in case of lymphedema.

Outcomes

	• Most of the neonates with hypoglycemia displayed normal glucose level within three weeks, although few cases required continuation of the treatments for 3 months.
	• Seizure control was obtained in the majority of individuals with seizures, most often without treatment (eg, in those with febrile seizures only; 19%) or with monotherapy (48%) (16).
	• Aggression and impulsivity improved significantly after two months of therapy with methylphenidate (38).
	• Surgical correction may be required for severe scoliosis not responsive to more conservative management.

References

01: Adhami EJ, Cancio-Babu CV. Anaesthesia in a child with Sotos syndrome. Paediatr Anesth 2003;13(9):835-40. PMID 14617129
02: Allanson JE, Cole TR. Sotos syndrome: evolution of facial phenotype subjective and objective assessment. Am J Med Genet 1996 65(1):13-20. Erratum in: Am J Med Genet 1998;79(3):229-30. PMID 8914735
03: Almuriekhi M, Shintani T, Fahiminiya S, et al. Loss-of-function mutation in APC2 causes Sotos syndrome features. Cell Rep 2015;10(9):1585-98. PMID 25753423
04: Balasubramanian M, Shearing E, Smith K, et al. Pneumothorax from subpleural blebs- A new association of sotos syndrome. Am J Med Genet A 2014;164(5):1222-6. PMID 24458726
05: Baujat G, Rio M, Rossignol S, et al. Clinical and molecular overlap in overgrowth syndromes. Am J Med Genet C Semin Med Genet 2005;137C(1):4-11. PMID 16010674
06: Brennan K, Zheng H, Fahrner JA, et al. NSD1 mutations deregulate transcription and DNA methylation of bivalent developmental genes in Sotos syndrome. Hum Mol Genet 2022;31(13):2164-84. PMID 35094088
07: Castronovo C, Rusconi D, Crippa M, et al. A novel mosaic NSD1 intragenic deletion in a patient with an atypical phenotype. Am J Med Genet A 2013;161A(3):611-8. PMID 23341071
08: Chierichini A, Messina A, Vergari A, et al. Regional anesthesia in a child with Sotos syndrome. Int J Immunopathol Pharmacol 2011;24:21-3. PMID 21669133
09: Choufani S, Cytrynbaum C, Chung BH, et al. NSD1 mutations generate a genome-wide DNA methylation signature. Nat Commun 2015;6:10207. PMID 26690673
10: Cole TR, Hughes HE. Sotos syndrome: a study of the diagnostic criteria and natural history. J Med Genet 1994;31(1):20-32. PMID 7512144
11: Corrado R, Wilson AF, Tello C, Noel M, Galaretto E, Bersusky E. Sotos syndrome and scoliosis surgical treatment: a 10-year follow-up. Eur Spine J 2011;20 Suppl 2:271-7. PMID 21225435
12: de Boer L, Roder I, Wit JM. Psychosocial, cognitive, and motor functioning in patients with suspected Sotos syndrome: a comparison between patients with and without NSD1 gene alterations. Dev Med Child Neurol 2006;48:582-8. PMID 16780628
13: Dolan M, Mendelsohn NJ, Pierpont ME, et al. A novel microdeletion/microduplication syndrome of 19p13.13. Genet Med 2010;12(8):503-511. PMID 20613546
14: Ferilli M, Ciolfi A, Pedace L, et al. Genome-wide DNA methylation profiling solves uncertainty in classifying NSD1 variants. Genes (Basel) 2022;13(11):2163. PMID 36421837
15: Fickie MR, Lapunzina P, Gentile JK, et al. Adults with Sotos syndrome: review of 21 adults with molecularly confirmed NSD1 alterations, including a detailed case report of the oldest person. Am J Med Genet Part A 2011;155:2105–11. PMID 21834047
16: Fortin O, Vincelette C, Khan AQ, et al. Seizures in Sotos syndrome: phenotyping in 49 patients. Epilepsia Open 2021;6(2):425-30. PMID 34033256
17: Foster A, Zachariou A, Loveday C, et al. The phenotype of Sotos syndrome in adulthood: a review of 44 individuals. Am J Med Genet C Semin Med Genet 2019;181(4):502-8. PMID 31479583
18: Gaudreau P, Zizak V, Gallagher TQ. The otolaryngologic manifestations of Sotos syndrome. Int J Pediatr Otorhinolaryngol 2013;77(11):1861-3. PMID 24060089
19: Grand K, Gonzalez-Gandolfi C, Ackermann AM, et al. Hyperinsulinemic hypoglycemia in seven patients with de novo NSD1 mutations. Am J Med Genet A 2019;179(4):542-51. PMID 30719864
20: Hood RL, McGillivray G, Hunter MF, et al. Severe connective tissue laxity including aortic dilatation in Sotos syndrome. Am J Med Genet A 2016;170A(2):531-5. PMID 26613968
21: Horikoshi H, Kato Z, Masuno M, et al. Neuroradiologic findings in Sotos syndrome. J Child Neurol 2006;21(7):614-8. PMID 16970856
22: Imaizumi K, Kimura J, Matsuo M, et al. Sotos syndrome associated with a de novo balanced reciprocal translocation t(5;8)(q35;q24.1). Am J Med Genet 2002;107(1):58-60. PMID 11807869
23: Inoue K, Kato S, Numaga J, et al. Optic disk pallor and retinal atrophy in Sotos syndrome (cerebral gigantism). Am J Ophthalmol 2000;130(6):853-4. PMID 11124319
24: Klaassens M, Morrogh D, Rosser EM, et al. Malan syndrome: Sotos-like overgrowth with de novo NFIX sequence variants and deletions in six new patients and a review of the literature. Eur J Hum Genet 2015;23(5):610-5. PMID 25118028
25: Kotilainen J, Pohjola P, Pirinen S, Arte S, Nieminen P. Premolar hypodontia is a common feature in Sotos syndrome with a mutation in the NSD1 gene. Am J Med Genet A 2009;149A(11):2409-14. PMID 19876911
26: Kurotaki N, Imaizumi K, Harada N, et al. Haploinsufficiency of NSD1 causes Sotos syndrome. Nat Genet 2002;30(4):365-6. PMID 11896389
27: Kurotaki N, Stankiewicz P, Wakui K, Niikawa N, Lupski JR. Sotos syndrome common deletion is mediated by directly oriented subunits within inverted Sos-REP low-copy repeats. Hum Mol Genet 2005;14(4):535-42. PMID 15640245
28: Lane C, Milne E, Freeth M. Cognition and behaviour in Sotos syndrome: a systematic review. PLoS One 2016;11(2):e0149189. PMID 26872390
29: Leventopoulos G, Kitsiou-Tzeli S, Kritikos K, et al. A clinical study of Sotos syndrome patients with review of the literature. Pediatr Neurol 2009;40(5):357-64.** PMID 19380072
30: Lourdes VH, Mario SC, Didac CA, et al. Beyond the known phenotype of sotos syndrome: a 31-individuals cohort study. Front Pediatr 2023;11:1184529. PMID 37384309
31: Malan V, Rajan D, Thomas S, et al. Distinct effects of allelic NFIX mutations on nonsense-mediated mRNA decay engender either a Sotos-like or a Marshall-Smith syndrome. Am J Hum Genet 2010;87:189-98.** PMID 20673863
32: Martinez F, Marín-Reina P, Sanchis-Calvo A, et al. Novel mutations of NFIX gene causing Marshall-Smith syndrome or Sotos-like syndrome: one gene, two phenotypes. Pediatr Res 2015;78(5):533-9. PMID 26200704
33: Matsuo T, Ihara K, Ochiai M, et al. Hyperinsulinemic hypoglycemia of infancy inSotos syndrome. Am J Med Genet Part A 2013;161A(1):34-7. PMID 23239432
34: Mayo S, Garin I, Monfort S, et al. Hypomethylation of the KCNQ1OT1 imprinting center of chromosome 11 associated to Sotos-like features. J Hum Genet 2012;57:153-6. PMID 22217647
35: Nagai T, Matsumoto N, Kurotaki N, et al. Sotos syndrome and haploinsufficiency of NSD1: clinical features of intragenic mutations and submicroscopic deletions. J Med Genet 2003;40(4):285-9. PMID 12676901
36: Nakamura Y, Takagi M, Yoshihashi H, et al. A case with neonatal hyperinsulinemic hypoglycemia: It is a characteristic complication of Sotos syndrome. Am J Med Genet A 2015;167A(5):1171-4. PMID 25712828
37: Nicita F, Ruggieri M, Polizzi A, et al. Seizures and epilepsy in Sotos syndrome: analysis of 19 Caucasian patients with long-term follow-up. Epilepsia 2012;53:e102-5. PMID 22352460
38: Niederhofer H. Efficacy of methylphenidate treatment in Sotos syndrome. Horm Res 2009;71(6):376. PMID 19506397
39: Niikawa N, Miyake N, Matsumoto N. Sotos Syndrome. In: Encyclopedia of Life Sciences. Chichester, UK: John Wiley & Sons, 2008:1-8.
40: Okamoto N, Toribe Y, Shimojima K, Yamamoto T. Tatton-Brown-Rahman syndrome due to 2p23 microdeletion. Am J Med Genet Part A 2016;170A(5):1339-42. PMID 26866722
41: Opitz JM, Weaver DW, Reynolds JF. The syndromes of Sotos and Weaver: reports and review. Am J Med Genet 1998;79(4):294-304. PMID 9781911
42: Priolo M, Grosso E, Mammì C, et al. A peculiar mutation in the DNA-binding/dimerization domain of NFIX causes Sotos-like overgrowth syndrome: a new case. Gene 2012;511:103-5. PMID 22982744
43: Priolo M, Schanze D, Tatton-Brown K, et al. Further delineation of Malan syndrome. Hum Mutat 2018;39(9):1226-37 PMID 29897170
44: Rayasam GV, Wendling O, Angrand PO, et al. NSD1 is essential for early post-implantation development and has a catalytically active SET domain. EMBO J 2003;22(12):3153-63. PMID 12805229
45: Saugier-Veber P, Bonnet C, Afenjar A, et al. Heterogeneity of NSD1 alterations in 116 patients with Sotos syndrome. Hum Mutat 2007;28(11):1098-107. PMID 17565729
46: Schaefer GB, Bodensteiner JB, Buehler BA, Lin A, Cole TR. The neuroimaging findings in Sotos syndrome. Am J Med Genet 1997;68(4):462-5. PMID 9021022
47: Schanze D, Neubauer D, Cormier-Daire V, et al. Deletions in the 3' part of the NFIXgene including a recurrent Alu-mediated deletion of exon 6 and 7 account for previously unexplained cases of Marshall-Smith syndrome. Hum Mutat 2014;35(9):1092-1100. PMID 24924640
48: Shimojima K, Okamoto N, Tamasaki A, Sangu N, Shimada S, Yamamoto T. An association of 19p13.2 microdeletions with Malan syndrome and Chiari malformation. Am J Med Genet Part A 2015;167A(4):724-30. PMID 25736188
49: Sotos JF, Dodge PR, Muirhead D, Crawford JD, Talbot NB. Cerebral gigantism in childhood. A syndrome of excessively rapid growth and acromegalic features and a nonprogressive neurologic disorder. New Engl J Med 1964;271:109-16. PMID 14148233
50: Su PH, Yu JS, Chen SJ, Chen JY, Tsao TF. Persistent falcine sinus and unilateral renal agenesis in a girl with Sotos syndrome. Clin Dysmorphol 2011;20(1):42-6. PMID 21084978
51: Tatton-Brown K, Douglas J, Coleman K, et al; Childhood Overgrowth Collaboration. Genotype-phenotype associations in Sotos syndrome: an analysis of 266 individuals with NSD1 aberrations. Am J Hum Genet 2005;77(2):193-204.** PMID 15942875
52: Tatton-Brown K, Murray A, Hanks S, et al. Weaver syndrome and EZH2 mutations: Clarifying the clinical phenotype. Am J Med Genet A 2013;161A(12):2972-80. PMID 24214728
53: Tatton-Brown K, Rahman N. Clinical features of NSD1-positive Sotos syndrome. Clin Dysmorphol 2004;13(4):199-204. PMID 15365454
54: Tatton-Brown K, Rahman N. Sotos syndrome. Eur J Hum Genet 2007;15(3):264-71.** PMID 16969376
55: Tatton-Brown K, Seal S, Ruark E, et al. Mutations in the DNA methyltransferase gene DNMT3A cause an overgrowth syndrome with intellectual disability. Nat Genet 2014;46(4):385-8. PMID 24614070
56: Thomas A, Lemire EG. Sotos syndrome: antenatal presentation. Am J Med Genet A 2008;146A(10):1312-3. PMID 18386800
57: Visser R, Landman EB, Goeman J, et al. Sotos syndrome is associated with deregulation of the MAPK/ERK-signaling pathway. PLoS One 2012;7(11):e49229. PMID 23155469
58: Visser R, Matsumoto N. Genetics of Sotos syndrome. Curr Opin Pediatr 2003;15(6):598-606. PMID 14631206
59: Visser R, Shimokawa O, Harada N, et al. Identification of a 3.0-kb major recombination hotspot in patients with Sotos syndrome who carry a common 1.9-Mb microdeletion. Am J Hum Genet 2005;76(1):52-67. PMID 15580547
60: Yoneda Y, Saitsu H, Touyama M, et al. Missense mutations in the DNA-binding/dimerization domain of NFIX cause Sotos-like features. J Hum Genet 2012;57:207-11. PMID 22301465
61: Zhang YL, Jing XY, Chen GL, Zhen L, Li DZ. Sotos syndrome: a study of antenatal presentation. Eur J Obstet Gynecol Reprod Biol 2022;279:1-4. PMID 36228445

Contributors

All contributors' financial relationships have been reviewed and mitigated to ensure that this and every other article is free from commercial bias.

Authors

Christina Grant MD PhD

Dr. Grant of Children’s National Hospital received a consulting fee from Amicus Therapeutics and honorariums from Sanofi Genzyme for serving on an advisory committee.
See Profile
Andrea Cohen MD

Dr. Cohen of the National Human Genome Research Institute has no relevant financial relationships to disclose.
See Profile

Editor

Ganeshwaran H Mochida MD

Dr. Mochida of Boston Children's Hospital and Harvard Medical School has no relevant financial relationships to disclose.
See Profile

Former Authors

Ghada M H Abdel-Salam MD
Harvey B Sarnat MS MD FRCPC
Tim A Benke MD (original author)

Patient Profile

Age range of presentation: 0 month to 12 years
Sex preponderance: male=female
Heredity: autosomal dominant but usually de novo
Population groups selectively affected: None selectively affected
Occupation groups selectively affected: None selectively affected

ICD & OMIM codes

ICD-9: Sotos syndrome: 253.0
ICD-10: Sotos syndrome: E22.0

Sotos syndrome: Q87.3
ICD-11: Sotos syndrome: LD2C
OMIM: Sotos syndrome: #117550

Malan syndrome: #614753

Intellectual developmental disorder, autosomal recessive 74: #617169

This is an article preview.
Start a Free Account
to access the full version.

Nearly 3,000 illustrations, including video clips of neurologic disorders.
Every article is reviewed by our esteemed Editorial Board for accuracy and currency.
Full spectrum of neurology in 1,200 comprehensive articles.
Listen to MedLink on the go with Audio versions of each article.

Questions or Comment?

MedLink®, LLC

3525 Del Mar Heights Rd, Ste 304
San Diego, CA 92130-2122

Toll Free (U.S. + Canada): 800-452-2400

US Number: +1-619-640-4660

Support: service@medlink.com

Editor: editor@medlink.com

ISSN: 2831-9125

Sotos syndrome

Differential Diagnosis

Weaver syndrome
Bannayan-Riley-Ruvalcaba syndrome
Beckwith-Wiedemann syndrome
Benign familial macrocephaly
Simpson-Golabi-Behmel syndrome
- Fragile X syndrome

Also Relevant

Acromegaly and gigantism
Fragile X syndrome
Hemimegalencephaly
Intellectual disability
Megalencephaly

Sotos syndrome

Introduction

Overview

Key points

Historical note and terminology

Clinical manifestations

Presentation and course

Prognosis and complications

Clinical vignette

Biological basis

Etiology and pathogenesis

Epidemiology

Prevention

Differential diagnosis

Confusing conditions

Diagnostic workup

Management

Outcomes

Special considerations

Pregnancy

Anesthesia

Media

References

Contributors

Authors

Editor

Former Authors

Patient Profile

ICD & OMIM codes

This is an article preview. Start a Free Account to access the full version.

Questions or Comment?

Also in This Category

X-linked hydrocephalus (L1 syndrome)

Cerebro-oculo-facio-skeletal syndrome

Schizencephaly

Fetal anticonvulsant syndrome

Rhombencephalosynapsis

Malformations of the brain

Von Hippel-Lindau disease

Vein of Galen malformations

This is an article preview.
Start a Free Account
to access the full version.